REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 181 filers reported holding REGENXBIO INC in Q3 2021. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $566,899 | -17.7% | 34,441 | -0.0% | 0.02% | -16.0% |
| Q2 2023 | $688,775 | +22.0% | 34,456 | +15.4% | 0.02% | +31.6% |
| Q1 2023 | $564,388 | +9.8% | 29,846 | +31.6% | 0.02% | +5.6% |
| Q4 2022 | $514,178 | -14.6% | 22,671 | -0.5% | 0.02% | -21.7% |
| Q3 2022 | $602,000 | -2.0% | 22,778 | -8.3% | 0.02% | +9.5% |
| Q2 2022 | $614,000 | -25.0% | 24,848 | +0.7% | 0.02% | -16.0% |
| Q1 2022 | $819,000 | +1.4% | 24,671 | -0.1% | 0.02% | +8.7% |
| Q4 2021 | $808,000 | -22.3% | 24,696 | -0.5% | 0.02% | -25.8% |
| Q3 2021 | $1,040,000 | +11.9% | 24,813 | +3.8% | 0.03% | +10.7% |
| Q2 2021 | $929,000 | +14.5% | 23,907 | +0.6% | 0.03% | +7.7% |
| Q1 2021 | $811,000 | +255.7% | 23,765 | +647.3% | 0.03% | +73.3% |
| Q2 2018 | $228,000 | – | 3,180 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |